Microba Life Sciences Balance Sheet Health
Financial Health criteria checks 5/6
Microba Life Sciences has a total shareholder equity of A$41.2M and total debt of A$395.4K, which brings its debt-to-equity ratio to 1%. Its total assets and total liabilities are A$58.0M and A$16.8M respectively.
Key information
1.0%
Debt to equity ratio
AU$395.39k
Debt
| Interest coverage ratio | n/a |
| Cash | AU$21.09m |
| Equity | AU$41.22m |
| Total liabilities | AU$16.82m |
| Total assets | AU$58.04m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: MAP's short term assets (A$32.2M) exceed its short term liabilities (A$12.4M).
Long Term Liabilities: MAP's short term assets (A$32.2M) exceed its long term liabilities (A$4.5M).
Debt to Equity History and Analysis
Debt Level: MAP has more cash than its total debt.
Reducing Debt: MAP's debt to equity ratio has reduced from 3.2% to 1% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: MAP has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: MAP has less than a year of cash runway if free cash flow continues to reduce at historical rates of 29.5% each year